| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 29 Jan 25 | APLS Apellis Pharmaceuticals | Common Stock | Sell | Dispose S | No | No | 29.5236 | 826 | 24.39 k | 1,147,716 |
| 22 Jan 25 | APLS Apellis Pharmaceuticals | Common Stock | Sell | Dispose S | No | No | 30.4255 | 3,948 | 120.12 k | 1,148,542 |
| 21 Jan 25 | APLS Apellis Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 15,045 | 0.00 | 1,152,490 |
| 17 Jan 25 | APLS Apellis Pharmaceuticals | Common Stock | Sell | Dispose S | No | No | 29.9582 | 750 | 22.47 k | 1,137,445 |
| 13 Jan 25 | APLS Apellis Pharmaceuticals | Common Stock | Sell | Dispose S | No | No | 28.7021 | 2,288 | 65.67 k | 1,138,195 |
| 20 May 24 | APLS Apellis Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 3.76 | 24,500 | 92.12 k | 1,140,483 |
| 20 May 24 | APLS Apellis Pharmaceuticals | Stock Option Common Stock | Option exercise | Dispose M | No | No | 3.76 | 24,500 | 92.12 k | 12,780 |
